Unicycive Therapeutics, Inc.UNCYNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-29.88M
↓ 135% vs avg
Percentile
P0
Near historical low
Streak
7 yr
Consecutive declineContracting
Average
$-12.71M
Historical baseline
PeriodValueYoY Change
TTM$-29.88M-4.3%
2024$-28.65M-56.6%
2023$-18.30M-16.9%
2022$-15.65M-170.1%
2021$-5.80M-297.3%
2020$-1.46M-24.1%
2019$-1.18M-51.7%
2018$-775000.00-